RELUGOLIX–ESTRADIOL–NORETHISTERONE (Ryeqo ®)
Clinical Indication
For treating moderate to severe symptoms of uterine fibroids in adults of reproductive age.
Comments
Initial 6 month prescription via specialist team before being transferred. DEXA scan arranged by secondary care at 1 year.
In line with NICE TA832
Date of classification
December 2022
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .